December 15, 2005
The World Health Organization on Wednesday added seven more drugs -- six produced by India's Aurobindo Pharma and one by South Africa's Aspen Pharmacare -- to its list of prequalified antiretroviral drugs, Reuters/Independent Online reports (Reuters/Independent Online, 12/14). All seven drugs have received approval or tentative approval from FDA, which assesses drugs in a similar way to WHO (Xinhua/People's Daily, 12/14). FDA in August agreed to begin sharing confidential information on its approvals of generic antiretroviral drugs with WHO in an effort to accelerate the distribution of low-cost medications worldwide (Kaiser Daily HIV/AIDS Report, 8/15). There are now 77 HIV/AIDS-related drugs that WHO recommends for use in developing countries (Reuters/Independent Online, 12/14). The addition of the FDA-approved drugs "adds value to the process by providing a wider selection of products of assured quality into a single comprehensive list," according to WHO (WHO release, 12/14).
Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2005 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.